Related Experiment Video
Updated: Mar 22, 2026

Method of Isolated Ex Vivo Lung Perfusion in a Rat Model: Lessons Learned from Developing a Rat EVLP Program
Published on: February 25, 2015
Early Experience with AngioVac Aspiration in the Pulmonary Arteries
Ramsey Al-Hakim1, Jonathan Park1, Anshuman Bansal1
1Department of Radiology, Division of Interventional Radiology, University of California, Los Angeles, 757 Westwood Plaza, Suite 1638, Los Angeles, CA 90095.
Abstract:
Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80%) presented with massive PE, and two (40%) were technically successful (reduction in Miller index ≥ 5). Four patients (80%) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.
Insights
The AngioVac aspiration cannula showed limited success in managing pulmonary embolism (PE), with high mortality and few technical successes. Further research and careful patient selection are needed for this interventional procedure.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Pulmonary Medicine
Background:
- Pulmonary embolism (PE) is a significant cause of morbidity and mortality.
- The AngioVac aspiration cannula is a device with potential applications in vascular interventions.
- Limited data exists on its efficacy and safety in managing PE.
Purpose of the Study:
- To retrospectively review the use of the AngioVac aspiration cannula in five consecutive patients with pulmonary embolism.
- To evaluate the technical success and clinical outcomes of this intervention for PE management.
Main Methods:
- Retrospective case series of five patients undergoing AngioVac aspiration for PE.
- Assessment of technical success based on reduction in the Miller index.
- Analysis of patient mortality and complications post-procedure.
Main Results:
- Four out of five patients (80%) presented with massive PE.
- Technical success (Miller index reduction ≥ 5) was achieved in two patients (40%).
- Four patients (80%) died within a mean of 7.3 days, with one death due to right ventricular perforation.
Conclusions:
- Early experience with the AngioVac aspiration cannula for PE management shows limited success and high mortality.
- Complications, including cardiac perforation, are a concern.
- Further investigation and stringent patient selection are crucial before wider adoption.
Related Concept Videos
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Pulmonary Embolism I: Introduction
Esophageal Varices-I: Introduction
Hemodialysis I: Introduction

